Sign in
4

Changes in Ownership

Compass Therapeutics, Inc. Filed Acc 0000899243-21-045309

Chief Operating Officer acquired 600,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Bisker-Leib Vered Chief Operating Officer 2021-11-16 Grant or award +600,000 1,113,401 D
Loading xslF345X03/doc4.xml…